Introduction: There is continued unmet medical need for new medicines across countries
especially for cancer, immunological diseases, and orphan diseases. However, there are …

Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …

Background: Countries across Africa and Asia have introduced a variety of measures to
prevent and treat COVID-19 with medicines and personal protective equipment (PPE) …

The prescription of generic drugs represents one of the main cost-containment strategies of
health systems, aimed at reducing pharmaceutical expenditure. In this context, most …

Introduction: There are appreciable concerns among European health authorities with
growing expenditure on cancer medicines and issues of sustainability. The enhanced use of …

Objective: Global expenditure on medicines is increasing driven by a number of factors.
These include the launch of new premium-priced medicines for complex diseases including …

Introduction There are increasing concerns regarding the inappropriate use of medicines
with expenditure continuing to grow driven by increasing sales in oncology and orphan …

Global expenditure on medicines is rising driven by increased expenditure on medicines for
immunological diseases, cancer and orphan diseases1. This is principally new biological …

Introduction Epilepsy affects nearly 50 million people around the world. As a common and
chronic disease generates a high cost burden for healthcare system and patients. Aim We …

Introduction: There are concerns over the quality of generic medicines in Pakistan. This is
due to perceived non-compliance with good manufacturing practice (GMP), whereby the …